Banned Carcinogen Being Used in Baby Products: Study

Researchers say that a flame retardant that may be a carcinogen is still being used in polyurethane foam contained in several baby products. 

Chemical flame retardants were banned from children’s pajamas more than three decades ago because of a possible cancer risk. However, at least one flame retardant, chlorinated Tris, has some researchers concerned after they found its presence in car seats, high chairs and other baby products.

According to a study published online by the Environmental Science & Technology on May 18, researchers conducted tests on 101 polyurethane foam baby products and found that 80 of them contained fire retardants. The most frequently used was tris (1,3-dichloroisopropy) phosphate (TDCPP), which was found in 36% of the products.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

TDCPP was banned in 1970s from use in children’s pajamas, but not other baby products. Flame retardants like TDCPP comprised up to 12% of some of the products tested.

Many polyurethane foam products are surrounded by a plastic covering, but it is unclear whether the coverings, which are sometimes ripped or chewed open by children, are effective in preventing the flame retardants from coming into contact with the children. However, the researchers estimated that the infants’ exposure to TDCPP likely exceeds acceptable daily intake levels set by the U.S. Consumer Product Safety Commission (CPSC).

Researchers also found other flame retardants, including Firemaster 55 and pentaBDE. Researchers in other studies have linked pentaBDE with neurodevelopmental impairment in children and the substance was banned in 2009 by the Stockhold Convention on Persistent Organic Pollutants.

The American Chemistry Council issued a statement noting that the study only examines the existence of flame retardants in children’s products, but does not actually address the amount of exposure or health risks to children.

The researchers said that future studies will be needed to determine the amount of exposure and any potential health risks.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.